Literature DB >> 10960051

Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5.

Y C Zang1, A K Samanta, J B Halder, J Hong, M V Tejada-Simon, V M Rivera, J Z Zhang.   

Abstract

Trafficking of inflammatory T cells into the central nervous system (CNS) plays an important role in the pathogenesis of multiple sclerosis. The directional migratory ability of peripheral T cells is associated with interactions of chemokines with their receptors expressed on T cells. In this study, transmigration of peripheral T cells toward a panel of chemokines was examined in patients with multiple sclerosis and healthy individuals using Boyden chemotactic transwells. A significantly increased migratory rate preferentially toward RANTES and MIP-1alpha, but not other chemokines, was found in T cells obtained from multiple sclerosis patients as opposed to healthy individuals (P: < 0.001). The migratory T-cell populations represented predominantly Th1/Th0 cells while non-migratory T cells were enriched for Th2-like cells. The study demonstrated further that aberrant migration of multiple sclerosis-derived T cells toward RANTES and MIP-1 alpha resulted from overexpression of their receptors (CCR5) and could be blocked by anti-CCR5 antibodies. These findings have important implications for our understanding of the mechanism underlying aberrant T cell trafficking in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960051     DOI: 10.1093/brain/123.9.1874

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  19 in total

1.  Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis.

Authors:  M Pashenkov; N Teleshova; M Kouwenhoven; V Kostulas; Y-M Huang; M Soderstrom; H Link
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  Expression of CCR2, CCR5, and CXCR3 by CD4+ T cells is stable during a 2-year longitudinal study but varies widely between individuals.

Authors:  Pia Kivisäkk; Corinna Trebst; Jar-Chi Lee; Barbara H Tucky; Richard A Rudick; James J Campbell; Richard M Ransohoff
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

3.  Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice.

Authors:  Koichi Kozaki; Wolfgang E Kaminski; Jingjing Tang; Stan Hollenbach; Per Lindahl; Carol Sullivan; Jin-Chen Yu; Keith Abe; Paul J Martin; Russell Ross; Christer Betsholtz; Neill A Giese; Elaine W Raines
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

4.  Haplotypes within genes of beta-chemokines in 17q11 are associated with multiple sclerosis: a second phase study.

Authors:  Tamara Vyshkina; Bernadette Kalman
Journal:  Hum Genet       Date:  2005-08-03       Impact factor: 4.132

5.  Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.

Authors:  H-F Dong; K Wigmore; M N Carrington; M Dean; J A Turpin; O M Z Howard
Journal:  Genes Immun       Date:  2005-10       Impact factor: 2.676

6.  The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/- mice.

Authors:  Jingjing Tang; Koichi Kozaki; Andrew G Farr; Paul J Martin; Per Lindahl; Christer Betsholtz; Elaine W Raines
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

7.  Leukocytic promotion of prostate cellular proliferation.

Authors:  Kristy L McDowell; Lesa A Begley; Nirit Mor-Vaknin; David M Markovitz; Jill A Macoska
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

8.  Brain endothelial tricellular junctions as novel sites for T cell diapedesis across the blood-brain barrier.

Authors:  Mariana Castro Dias; Adolfo Odriozola Quesada; Sasha Soldati; Fabio Bösch; Isabelle Gruber; Tobias Hildbrand; Derya Sönmez; Tejas Khire; Guillaume Witz; James L McGrath; Jörg Piontek; Masuo Kondoh; Urban Deutsch; Benoît Zuber; Britta Engelhardt
Journal:  J Cell Sci       Date:  2021-04-26       Impact factor: 5.285

9.  Involvement of beta-chemokines in the development of inflammatory demyelination.

Authors:  Ileana Banisor; Thomas P Leist; Bernadette Kalman
Journal:  J Neuroinflammation       Date:  2005-02-24       Impact factor: 8.322

Review 10.  Chemokine receptors on dendritic cells promote autoimmune reactions.

Authors:  Joost J Oppenheim; De Yang; Arya Biragyn; O M Zack Howard; Paul Plotz
Journal:  Arthritis Res       Date:  2002-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.